Literature DB >> 21326825

Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells.

Aviad Levin1, Zvi Hayouka, Assaf Friedler, Abraham Loyter.   

Abstract

Unlike other retroviruses, human immunodeficiency virus type-1 (HIV-1) can infect terminally differentiated cells, due to the ability of its pre-integration complex (PIC) to translocate via the host nuclear pore complex (NPC). The PIC Nuclear import has been suggested to be mediated by the viral integrase protein (IN), via either the importin α or transportin 3 (TNPO3/transportin-SR2) pathways.We show that in virus-infected cells, IN interacts with both importin α and TNPO3, simultaneously or separately, suggesting a multiple use of nuclear import pathways. Disruption of either the IN-importin α or IN-TNPO3 complexes in virus-infected cells by specific cell-permeable-peptides resulted in inhibition of IN and viral cDNA nuclear import. Here we show that peptides which disrupt either one of these complexes block virus infection, indicating involvement of both pathways in efficient viral replication. Formation of IN-importin α and IN-TNPO3 complexes has also been observed in IN-transfected cultured cells. Using specific peptides, we demonstrate that in transfected cells but not in virus infected cells the importin α pathway overrides that of TNPO3. The IN-importin α and IN-TNPO3 complexes were not observed in virus-infected Rev-expressing cells, indicating the Rev protein's ability to disrupt both complexes.Our work suggests that IN nuclear import requires the involvement of both importin α and TNPO3. The ability to inhibit nuclear import of the IN-DNA complex and consequently, virus infection by peptides that interrupt IN's interaction with either importin α or TNPO3 indicates that for efficient infection, nuclear import of IN should be mediated by both nuclear-import receptors.

Entities:  

Keywords:  HIV-1; importin; integrase; nuclear import; transportin 3

Mesh:

Substances:

Year:  2010        PMID: 21326825      PMCID: PMC3037538          DOI: 10.4161/nucl.1.5.12903

Source DB:  PubMed          Journal:  Nucleus        ISSN: 1949-1034            Impact factor:   4.197


  66 in total

1.  Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay.

Authors:  Anna Casabianca; Caterina Gori; Chiara Orlandi; Federica Forbici; Carlo Federico Perno; Mauro Magnani
Journal:  Mol Cell Probes       Date:  2007-05-21       Impact factor: 2.365

2.  Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium.

Authors:  Zvi Hayouka; Joseph Rosenbluh; Aviad Levin; Shoshana Loya; Mario Lebendiker; Dmitry Veprintsev; Moshe Kotler; Amnon Hizi; Abraham Loyter; Assaf Friedler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

3.  Peptides derived from HIV-1 Rev inhibit HIV-1 integrase in a shiftide mechanism.

Authors:  Zvi Hayouka; Joseph Rosenbluh; Aviad Levin; Michal Maes; Abraham Loyter; Assaf Friedler
Journal:  Biopolymers       Date:  2008       Impact factor: 2.505

4.  Over-expression of the HIV-1 Rev promotes death of nondividing eukaryotic cells.

Authors:  Aviad Levin; Zvi Hayouka; Assaf Friedler; Abraham Loyter
Journal:  Virus Genes       Date:  2010-02-12       Impact factor: 2.332

5.  A novel role for the viral Rev protein in promoting resistance to superinfection by human immunodeficiency virus type 1.

Authors:  Aviad Levin; Zvi Hayouka; Assaf Friedler; Ruth Brack-Werner; David J Volsky; Abraham Loyter
Journal:  J Gen Virol       Date:  2010-02-10       Impact factor: 3.891

6.  Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.

Authors:  Ayelet Armon-Omer; Aviad Levin; Zvi Hayouka; Karin Butz; Felix Hoppe-Seyler; Shoshana Loya; Amnon Hizi; Assaf Friedler; Abraham Loyter
Journal:  J Mol Biol       Date:  2007-12-05       Impact factor: 5.469

7.  Identification of host proteins required for HIV infection through a functional genomic screen.

Authors:  Abraham L Brass; Derek M Dykxhoorn; Yair Benita; Nan Yan; Alan Engelman; Ramnik J Xavier; Judy Lieberman; Stephen J Elledge
Journal:  Science       Date:  2008-01-10       Impact factor: 47.728

8.  A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal.

Authors:  Ayelet Armon-Omer; Adolf Graessmann; Abraham Loyter
Journal:  J Mol Biol       Date:  2004-03-05       Impact factor: 5.469

9.  Human immunodeficiency virus type 1 DNA nuclear import and integration are mitosis independent in cycling cells.

Authors:  Richard A Katz; James G Greger; Pamela Boimel; Anna Marie Skalka
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells.

Authors:  Masahiro Yamashita; Omar Perez; Thomas J Hope; Michael Emerman
Journal:  PLoS Pathog       Date:  2007-10-26       Impact factor: 6.823

View more
  25 in total

1.  TNPO3 is required for HIV-1 replication after nuclear import but prior to integration and binds the HIV-1 core.

Authors:  Jose Carlos Valle-Casuso; Francesca Di Nunzio; Yang Yang; Natalia Reszka; Maritza Lienlaf; Nathalie Arhel; Patricio Perez; Abraham L Brass; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

2.  The HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration.

Authors:  Kallesh Danappa Jayappa; Zhujun Ao; Xiaojian Yao
Journal:  Int J Biochem Mol Biol       Date:  2012-02-25

3.  TNPO3-Mediated Nuclear Entry of the Rous Sarcoma Virus Gag Protein Is Independent of the Cargo-Binding Domain.

Authors:  Breanna L Rice; Matthew S Stake; Leslie J Parent
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

4.  N-terminal half of transportin SR2 interacts with HIV integrase.

Authors:  Vicky G Tsirkone; Jolien Blokken; Flore De Wit; Jolien Breemans; Stéphanie De Houwer; Zeger Debyser; Frauke Christ; Sergei V Strelkov
Journal:  J Biol Chem       Date:  2017-03-29       Impact factor: 5.157

5.  A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells.

Authors:  Judd F Hultquist; Kathrin Schumann; Jonathan M Woo; Lara Manganaro; Michael J McGregor; Jennifer Doudna; Viviana Simon; Nevan J Krogan; Alexander Marson
Journal:  Cell Rep       Date:  2016-10-25       Impact factor: 9.423

Review 6.  Diversification of importin-α isoforms in cellular trafficking and disease states.

Authors:  Ruth A Pumroy; Gino Cingolani
Journal:  Biochem J       Date:  2015-02-15       Impact factor: 3.857

7.  Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication.

Authors:  Francesca Di Nunzio; Thomas Fricke; Annarita Miccio; Jose Carlos Valle-Casuso; Patricio Perez; Philippe Souque; Ermanno Rizzi; Marco Severgnini; Fulvio Mavilio; Pierre Charneau; Felipe Diaz-Griffero
Journal:  Virology       Date:  2013-03-21       Impact factor: 3.616

8.  Peptides derived from the HIV-1 integrase promote HIV-1 infection and multi-integration of viral cDNA in LEDGF/p75-knockdown cells.

Authors:  Aviad Levin; Zvi Hayouka; Assaf Friedler; Abraham Loyter
Journal:  Virol J       Date:  2010-08-02       Impact factor: 4.099

9.  Conserved arginines of bovine adenovirus-3 33K protein are important for transportin-3 mediated transport and virus replication.

Authors:  Vikas Kulshreshtha; Lisanework E Ayalew; Azharul Islam; Suresh K Tikoo
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

10.  Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Translocation in Nondividing Cells.

Authors:  Cindy Buffone; Alicia Martinez-Lopez; Thomas Fricke; Silvana Opp; Marco Severgnini; Ingrid Cifola; Luca Petiti; Stella Frabetti; Katarzyna Skorupka; Kaneil K Zadrozny; Barbie K Ganser-Pornillos; Owen Pornillos; Francesca Di Nunzio; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.